| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5582057 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 17 Pages |
Abstract
Our data, although from a small series, suggest that the blood ACD4C might be a predictor of PFS for patients with DLBCL, independent of age and the IPI.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Julia Judd, Essel Dulaimi, Tianyu Li, Michael M. Millenson, Hossein Borghaei, Mitchell R. Smith, Tahseen Al-Saleem,